Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe Crohn's disease, and ulcerative colitis; and Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still's disease, including adult-onset still's disease and systemic juvenile idiopathic arthritis. Its products for rare genetic diseases in Phase III clinical trials include AVTX-801, a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, a L-fucose substrate replacement therapy for the treatment of LADII, also known as SLC35C1-CDG. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Avalo Therapeutics Inc..
Avalo Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Avalo Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Avalo Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Avalo Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Avalo Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Avalo Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Avalo Therapeutics Inc.- Key Facts
2.2 Avalo Therapeutics Inc.- Geographic Locations
2.3 Avalo Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Avalo Therapeutics Inc.- Business Divisions
2.5 Avalo Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Avalo Therapeutics Inc. Strategic Analysis Review
3.1 Avalo Therapeutics Inc.- Key Strategies
3.2 Avalo Therapeutics Inc.- Company Outlook Statement
3.3 Avalo Therapeutics Inc.- SWOT Analysis
3.3.1 Avalo Therapeutics Inc.- Key Strengths
3.3.2 Avalo Therapeutics Inc.- Key Weaknesses
3.3.3 Avalo Therapeutics Inc.- Potential Opportunities
3.3.4 Avalo Therapeutics Inc.- Potential Threats
3.4 Avalo Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Avalo Therapeutics Inc.- Business Overview
4.2 Avalo Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Avalo Therapeutics Inc.- Key Products
5.2 Avalo Therapeutics Inc.- Key Service Areas
5.3 Avalo Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Avalo Therapeutics Inc.- Company History
6.2 Avalo Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Avalo Therapeutics Inc.- Income Statements
7.2 Avalo Therapeutics Inc.- Balance Sheet
7.3 Avalo Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Avalo Therapeutics Inc.- Direct Competitors
8.2 Avalo Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Avalo Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Avalo Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!